| Impact of blinding on patient-reported outcome differences between treatment arms in cancer randomized controlled trials F Efficace, D Cella, NK Aaronson, M Calvert, F Cottone, M Di Maio, ... JNCI: Journal of the National Cancer Institute 114 (3), 471-474, 2022 | 23 | 2022 |
| Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review F Sparano, M Cavo, P Niscola, T Caravita, F Efficace Supportive Care in Cancer 26, 2075-2090, 2018 | 23 | 2018 |
| Investigating the impact of open label design on patient‐reported outcome results in prostate cancer randomized controlled trials G Mouillet, F Efficace, A Thiery‐Vuillemin, E Charton, M Van Hemelrijck, ... Cancer Medicine, 2020 | 20 | 2020 |
| Chimeric antigen receptor T-cell therapy in hematologic malignancies and patient-reported outcomes: a scoping review F Efficace, L Cannella, F Sparano, JM Giesinger, M Vignetti, F Baron, ... Hemasphere 6 (12), e802, 2022 | 13 | 2022 |
| Differences in patient-reported outcomes that are most frequently detected in randomized controlled trials in patients with solid tumors: a pooled analysis of 229 trials JM Giesinger, J Blazeby, NK Aaronson, M Sprangers, P Fayers, ... Value in Health 23 (5), 666-673, 2020 | 13 | 2020 |
| Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review M Van Hemelrijck, F Sparano, D Josephs, M Sprangers, F Cottone, ... BMC urology 19, 1-11, 2019 | 11 | 2019 |
| Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient‐reported outcomes in randomized controlled trials to support clinical decision … M Van Hemelrijck, F Sparano, L Moris, K Beyer, F Cottone, M Sprangers, ... Cancer Medicine 9 (12), 4039-4058, 2020 | 10 | 2020 |
| Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review F Sparano, NK Aaronson, MAG Sprangers, P Fayers, A Pusic, JM Kieffer, ... BMJ supportive & palliative care 9 (4), 451-463, 2019 | 8 | 2019 |
| Patient-reported outcomes in randomized controlled trials of patients with multiple myeloma: a systematic literature review of studies published between 2014 and 2021 F Efficace, F Cottone, F Sparano, G Caocci, M Vignetti, R Chakraborty Clinical Lymphoma Myeloma and Leukemia 22 (7), 442-459, 2022 | 7 | 2022 |
| Investigating trends in the quality of reporting of patient-reported outcomes in oncology over time: analysis of 631 randomized controlled trials published between 2004 and 2019 F Efficace, JM Giesinger, D Cella, F Cottone, F Sparano, M Vignetti, ... Value in Health 24 (12), 1715-1719, 2021 | 7 | 2021 |
| Optimizing health-related quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors F Efficace, M Vignetti, F Sparano, E Scalzulli, M Breccia Expert Review of Hematology 14 (3), 293-302, 2021 | 5 | 2021 |
| Health-related quality of life assessment in patients with myelodysplastic syndromes: evidence from randomized clinical trials JM Giesinger, G La Nasa, F Sparano, M Angermeyer, E Morelli, O Mulas, ... Clinical Practice and Epidemiology in Mental Health: CP & EMH 17 (Supp-1), 307, 2021 | 5 | 2021 |
| Perché bisogna garantire a tutti l’accesso alle riviste scientifiche G Borrelli, F Sparano L’Internazionale October 7, 2019, 2019 | 5 | 2019 |
| Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the … F Efficace, A Patriarca, M Luppi, L Potenza, G Caocci, A Tafuri, F Fazio, ... Frontiers in Oncology 12, 826040, 2022 | 4 | 2022 |
| Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes? F Sparano, NK Aaronson, F Cottone, A Piciocchi, E La Sala, A Anota, ... Journal of Comparative Effectiveness Research 8 (5), 279-288, 2019 | 4 | 2019 |
| La medicina è anche cura sociale: l’esperienza delle Case della salute G Borrelli, F Sparano Altreconomia, 2021 | 3 | 2021 |
| Dieci anni di definanziamento della sanità pubblica: dato per dato F Sparano | 2 | 2021 |
| Does the quality of patient-reported outcomes (PROs) assessment in randomized controlled trials (RCTs) differ across cancer types and over time? A pooled analysis of 610 RCTs … F Sparano, NK Aaronson, MAG Sprangers, P Fayers, A Pusic, JM Kieffer, ... Journal of Clinical Oncology 37 (15_suppl), e18218-e18218, 2019 | 1 | 2019 |
| Inclusion of patient-reported outcomes (PROs) in randomized controlled trials (RCTs) with elderly cancer patients: A systematic review. F Sparano, NK Aaronson, MAG Sprangers, P Fayers, A Pusic, JM Kieffer, ... Journal of Clinical Oncology 37 (15_suppl), e18217-e18217, 2019 | 1 | 2019 |
| Patient-reported outcome assessment in acute leukemias: Moving beyond the barriers. F Efficace, F Cottone, F Sparano, F Lo-Coco Cancer 124 (14), 3066-3067, 2018 | 1 | 2018 |
Pasquale NiscolaDirigente Medico, UOC Ematologia, Day Hospital Ematologico CTO, Ospedale S.Eugenio-CTO (ASL Roma 2Email verificata su aslroma2.it
